CRISPR/Cas9 and other gene-editing technologies are being used at our Lab to precisely modify genes within a patient’s cells to correct mutations that cause disease. This can include knocking out, replacing, or adding genes to correct defects or confer new functions.
Chimeric Antigen Receptor T-cell (CAR-T) Therapy: In CAR-T cell therapy, patient-derived T-cells are genetically modified to express a receptor specific to cancer cells. The lab has the capability for the collection, genetic modification, and expansion of these cells before infusion back into the patient.
Let's Talk
Meydan Grandstand, 6th floor, Meydan Road, Nad Al Sheba, Dubai, U.A.E.
Monday - Friday 800 - 1600